19
Mar

Private equity outfit GTCR has recruited two industry veterans and put up $300 million to create Maravai Life Sciences, a buyout-focused firm out to make some deals.

…read more

Source: With a $300M buyout fund, Maravai sets out to make a biotech splash

    

0 No comments